Improving cancer recognition and referral in primary care
Dr Anthony Cunliffe outlines the new service specifications for primary care networks, and explains how they will facilitate earlier diagnosis of cancer
Supporting primary care to recognise cancer in the COVID-19 era
Dr Anthony Cunliffe discusses barriers to cancer diagnosis and investigations imposed by the pandemic and how to overcome them
Top tips: mental health and cancer in adults
Dr Sadaf Haque offers 10 top tips for primary care on the identification and management of mental health problems in adults with cancer
Top tips: colorectal cancer
Dr Richard Roope provides top tips for GPs about identifying possible colorectal cancer and supporting patients to reduce risk and achieve the best outcomes
Top tips: personalising cancer care
Dr Anthony Cunliffe shares 10 top tips for primary care on the provision of personalised care for people with cancer
Unintended weight loss: what’s the diagnosis?
Dr Sonya Jey explains the importance of considering and excluding sinister causes of unintentional weight loss and explores some clinical scenarios in which unintentional weight loss is a feature
Specialist support for your patients with cancer - Macmillan’s Support Line can help.
From clinical information to emotional support, and advice on money and work, the Macmillan Support Line will do whatever it takes to support your patients. Learn more here.
Our multiple-choice questions (MCQs) are designed to help you test your knowledge and reflect on your learning after reading an article.
Reflecting on cancer recognition and referral
Use this reflective template to reflect on your learning after reading Improving cancer recognition and referral in primary care.
Best practice in pancreatic cancer
This CPD activity consists of 5 multiple-choice questions (MCQs) designed to test your knowledge on pancreatic cancer in primary care—you will then be prompted to reflect on your learning.
Educational resources
Exploring decisions surrounding the optimisation of Androgen Deprivation Therapy (ADT) use for appropriate prostate cancer (PCa) patients in the NHS in light of COVID-19
Information intended for UK healthcare professionals only. This promotional supplement has been commissioned and funded by Ipsen UK Ltd and developed in partnership with Guidelines in Practice.
View DECAPEPTYL® SR (triptorelin) 3mg, DECAPEPTYL® SR (triptorelin) 11.25mg and DECAPEPTYL® SR (triptorelin) 22.5mg prescribing information and adverse event reporting information here
TRI-UK-004677
Date of preparation: October 2021
Best practice in the management of advanced breast cancer: the role of CDK4/6 inhibitors versus chemotherapy – A Pfizer sponsored roundtable discussion
This content has been produced in line with the IBRANCE®▼ (palbociclib) Summary of Product Characteristics for Great Britain. This piece is intended for GB healthcare professionals only. This roundtable discussion has been commissioned and funded by Pfizer Ltd and developed in partnership with Guidelines in Practice.
Prescribing information and adverse event reporting information for IBRANCE® (palbociclib) for Great Britain can be accessed here
PP-IBR-GBR-3703 | Date of preparation: October 2021
Disease-modifying anti-rheumatic drugs (DMARDS) guidelines: a focus on methotrexate guidance in clinical practice
Information intended for UK healthcare professionals only. This webinar was initiated and commissioned by Accord-UK Ltd and developed in partnership with Guidelines in Practice.
View Methofill® (methotrexate) pre-filled injector and pre-filled syringe prescribing information and adverse event reporting information here
View the Summary of Product Characteristics for Folic Acid 5mg Tablets; Legal Cat POM; NHS List price 90p
UK-02645
Date of preparation: September 2021
Prostap® DCS (leuprorelin acetate)—a 3-monthly gonadotrophin-releasing hormone (GnRH) agonist treatment for breast cancer
Information intended for UK healthcare professionals only. This round-table discussion supplement has been commissioned and funded by Takeda UK Ltd and developed in partnership with Guidelines in Practice.
View prescribing information
C-APROM/UK/PRS/0152
Date of preparation: April 2021
Real-world usage study and survey of oral bowel cleansing for colonoscopy in Dudley, UK
This supplement has been commissioned by Norgine Pharmaceuticals Limited and contains promotional information. Information for healthcare professionals only.
Click here for PLENVU® (macrogol 3350, sodium ascorbate, ascorbic acid, sodium sulfate anhydrous, potassium chloride, sodium chloride) Prescribing and Adverse Event Reporting.
Click here for MOVIPREP® ((macrogol 3350, sodium sulfate anhydrous, ascorbic acid, sodium ascorbate, sodium chloride, and potassium chloride) Prescribing and Adverse Event Reporting.
Click here for KLEAN-PREP (macrogol 3350, anhydrous sodium sulfate, sodium bicarbonate, sodium chloride, potassium chloride) Prescribing and Adverse Event Reporting.
UK-GE-PLV-2000027
Date of preparation: February 2021
Related Guidelines summaries
-
RPS cancer support guideline
A summary of initiatives that utilise the skill mix of community pharmacy teams to support people with cancer within the community
-
COVID-19 rapid guideline on systemic anticancer treatments
This summary aims to maximise the safety of patients with cancer and make the best use of NHS resources, while protecting staff from infection
-
NICE suspected cancer in primary care guideline
A summary of guidance to assist GPs on the recognition and referral of suspected cancer
-
PHE PSA prostate cancer test guideline
A concise summary of PHE's guidance on PSA testing in men over 50 years old. Includes a useful algorithm.
-
NICE breast cancer guideline
An easy-to-read NICE guidance summary on the classification and care of people at risk of familial breast cancer or with a family history of breast cancer.